sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
×Ô¾õÐÔ¸ßѪѹ¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > ×Ô¾õÐÔ¸ßѪѹ¶¯ÎïÄ£×Ó

Ç°ÑÔ

¸ßѪѹÊÇÌåÑ­»·¶¯ÂöѹÔö¸ßµÄÒ»ÖÖ³£¼ûÐÄѪ¹Ü¼²²¡£¬ÓÉ»ùÒòºÍÇéÐζàÒòËØÏ໥×÷ÓÃÒýÆð£¬ÊÇÈ«Çò¹æÄ£ÄÚµÄÖØÖÁ¹«¹²ÎÀÉúÎÊÌ⣬¿É·ÖΪԭ·¢ÐÔ¸ßѪѹºÍ¼Ì·¢ÐÔ¸ßѪѹÁ½´óÀà¡£¸ßѪѹ¿ÉÒýÆðÉíÌå¶àÆ÷¹ÙË𺦣¬ÒÔÐÄ¡¢ÄÔ¡¢ÉöΪÖ÷¡£ÓÉÓÚ¸ßѪѹ·¢²¡ÒòËØÖØ´ó£¬ÓÖÊǶàÖÖ¼²²¡µÄΣÏÕÒòËØ£¬Òò´ËÐèÒª²î±ð¶¯ÎïÄ£×ÓÇø·Ö²î±ðÒÅ´«ºÍÇéÐÎÒòËØ£¬ÓÃÓÚÑо¿¸ßѪѹ²¡µÄ·¢²¡»úÖÆÒÔ¼°ºÍÆäËû¼²²¡µÄ¹Øϵ£¬ÕÒµ½Ô¤·ÀºÍÖÎÁƵÄÒªÁì¡£

¸ßѪѹ¶¯ÎïÄ£×Óƾ֤ÔìÄ£·½·¨¿ÉÒÔ·ÖΪÒÅ´«ÐÔÄ£×ӺͷÇÒÅ´«ÐÔÄ£×ÓÒÅ´«ÐÔÄ£×ÓÓеÄÊÇͨ¹ý½ü½»Ïµ×ÌÉúºÍ±íÐÍɸѡ£¬½¨Éè×ÔȻͻ±äµÄƷϵ£¬¶àÊÇ´óÊóÄ£×Ó¡£ÁíÒ»·½Ãæ¿ÉÒÔʹÓûùÒò¹¤³ÌÊÖÒÕ£¬Í¨¹ý»ùÒòÐÞÊλñµÃ¸ßѪѹģ×Ó¡£ÓÉÓÚСÊóµÄת»ùÒòºÍ»ùÒòÇóýÊÖÒյijÉÊ죬ÕâÀàÄ£×ÓÒÔСÊóÄ£×ÓΪÖ÷¡£·ÇÒÅ´«ÐÔÄ£×Ó¿ÉÒÔͨ¹ýÉöѪ¹ÜÊÖÊõ»ò¼¤ËØ¡¢Òûʳ¡¢Ò©Îï¡¢Ó¦¼¤µÈÓÕµ¼·½·¨ÖƱ¸¡£¶øÒÅ´«ÐÔÄ£×ӺͷÇÒÅ´«ÐÔÄ£×ÓµÄÏ໥͎ᣬ¸ü¿ÉÒÔÑо¿»ùÒòºÍÇéÐÎÒòËصÄÏ໥ӰÏì¡£½øÒ»²½ÍŽáÆäËûÏà¹Ø¼²²¡»ò æé¹ÙËðº¦Ä£×Ó£¬ÀýÈç¸ß֬Ѫ֢ģ×Ó¡¢ÒȵºËضԿ¹Ä£×Ó¡¢·ÊÅÖÄ£×ӵȣ¬Îª¸ßѪѹºÍÆäËû¼²²¡Ï໥¹ØϵµÄÑо¿ÒÔ¼°Ïà¹ØÖÎÁÆÒªÁìµÄ¡¢Ñо¿ÌṩºÜºÃµÄÑо¿¹¤¾ß¡£×ÜÖ®£¬ÏÖÔÚÑо¿¸ßѪѹ½ÓÄɶàÒòËصĶ¯ÎïÄ£×ӽ϶࣬¶¯ÎïÖÖÀàÒÔСÊó¡¢´óÊóÄ£×ÓΪÖ÷¡£Ëæ×Å´óÊóµÄ»ùÒòÇóýºÍת»ùÒòÊÖÒÕµÄÖð²½½¨ÉèÆðÀ´£¬ÆäÔÚ¸ßѪѹģ×ÓÖÐÓ¦ÓõÄÔöÌí½«Öð²½µØÌ滻СÊó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

×Ô¾õÐÔ¸ßѪѹ´óÊó(spontaneously hypertensive rat,SHR)ÊÇ1963ÄêOkamotoºÍAokiÅàÓý¶ø³ÉµÄ½ü½»ÏµWistar´óÊó¼°Æä±ÈÕÕϵ½ü½»ÏµWistar-Kyolo´óÊó¡£SHR´óÊó¸ßѪѹµÄ·¢²¡ºÍÐÄÊä³öÁ¿ÔöÌíÓйØ¡£Ëæ¸ßѪѹϣÍû£¬ÐÄÊä³öÁ¿»Ö¸´Õý³££¬¶ø×ÜÍâÖÜ×èÁ¦ÔöÌí¡£ºã¾Ã¿ÉÒýÆðÐļ¡·Ê´óºÍ³äѪÐÔÐĹ¦Ð§Ë¥½ß¡£

Ò××äÖÐÐÔ×Ô¾õÐÔ¸ßѪѹ´óÊó(stroke prone spontaneously hypertensive rat,SHRsp)ÊÇYamoriµÈ´Ó×ÔÈ»ËÀÓÚÄÔ×äÖеÄSHR´óÊó×ÓÅ®Öнü½»ÅàÓý¶ø³É¡£SHRºÍÆäÒõÐÔ±ÈÕÕÔÓ½»µÄµÚÒ»´úС×У¬±»³ÆΪÁÙ½çÐÔ¸ßѪѹ´óÊó(borderline hypertensive rat£¬BHR)£¬ÊÇÒ»Àà¶Ô¸ßѪѹÏà¹ØµÄÇéÐÎÒòËØÊ®·ÖÃô¸ÐµÄÄ£×Ó¡£ÑÎÃô¸ÐÐÔ´óÊó(Dahl salt-sensitive rat,DS)Ò²ÊÇÒ»Àà½ü½»ÏµÉ¸Ñ¡Ä£×Ó¡£±ðµÄһЩ·ÊÅÖÄ£×ÓÒ²±»ÒÔΪÊÇ×Ô¾õÐÔ¸ßѪѹģ×Ó¡£

¡¾Ä£×ÓÌص㡿£º

SHR(4~6ÖÜÁ䣩ÔÚÎÞÈκÎÎïÀíÒ©Îï¡¢ÊÖÊõµÈÒòËØÏ£¬×Ô¾õ¸ßѪѹ£¬¿ÉÊÇÇéÐÎÒòËØÓ°Ïì¸ßѪѹµÄˮƽ¡£¸ÃÄ£×Ó¶Ôζȡ¢Éù¡¢¹âµÈËÇÑøÇéÐÎÒªÇóÑÏ¿á¡£SHRËõ¶Ìѹͨ³£ÔÚ160mmHg (21.33kPa)ÒÔÉÏ£¬13ÖÜ×óÓÒ£¬Ðļ¡Ï¸°û·Ê´ó£¬24Öܺó×óÐÄÊұڷʺñ¾ÙÐÐÐÔ¼ÓÖØ£¬Ðļ¡½ºÔ­º¬Á¿ÏÔ×ÅÔöÌí£¬ÒÔºóÒòÈÕÒæ¼ÓÖصÄÐļ¡ÏËά»¯ºÍÐļ¡¼äÖÊÖع¹¶øÒýÆðÐÄÔàÊæËõ¹¦Ð§ÕÏ°­¡£SHRspÄ£×Ó6ÖÜѪѹ×îÏÈÉý¸ß£¬5¡«6ÔÂÁä´ïá¯Áë(230~250mmHg)¡£ÐÛÐÔƽ¾ùÊÙÃü9¸öÔ£¬´ÆÐÔ12¸öÔ£¬80£¥ÐÛÐÔ£¬60%´ÆÐÔ±¬·¢ÄÔ×äÖС£

¡¾Ä£×ÓȪԴ¡¿£º

SHRÏÖÔÚ³£ÓõÄÊÇÓÉOkamotoµÈÅàÓýµÄ¾©¶¼ÖÖ£¬ÆäËûÉÐÓжàÖÖȪԴµÄSHR´óÊó¡£ÎÒ¹úÉϺ£¸ßѪѹÑо¿Ëù¶¯ÎïʵÑéÖÐÐĵȵ¥Î»¿ÉÌṩSHR¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

SHR´óÊóÔÚ·¢²¡Ôµ¹ÊÔ­ÓÉÉÏÓëÈËÀà¸ßѪѹÓÐÒ»¶¨²î±ð£¬µ«´ÓÐí¶à·½ÃæÀ´½²£¬Èç·¢²¡»úÖÆ¡¢¸ßѪѹÐÄѪ¹Ü²¢·¢Ö¢¡¢ÍâÖÜѪ¹Ü×èÁ¦×ª±ä¡¢¶ÔÑεÄÃô¸ÐÐԵȶ¼ÓëÈËÀà¸ßѪѹ»¼ÕßÏàËÆ£¬ÊÇÏÖÔÚ¹ú¼Ê¹«ÈÏ×î¿¿½üÓÚÈËÀàÔ­·¢ÐÔ¸ßѪѹµÄ¶¯ÎïÄ£×Ó£¬¿ÉÓÃÓÚ¸ßѪѹ¼°²¢·¢Ö¢·¢²¡»úÖÆÑо¿£¬ÊǽµÑ¹Ò©Îïɸѡ»òҩЧÆÀ¼ÛµÄÀíÏëʵÑ鶯ÎïÄ£×Ó¡£

SHPspÄ£×ÓÊǹú¼Ê¸ßѪѹЭ»á¸ßѪѹ´óÊóÃüÃûίԱ»á(1986Äê8ÔµÚ11½ì¹ú¼Ê¸ßѪѹ¾Û»á£©ÍƼöµÄ¸ßѪѹʵÑéÄ£×Ó£¬ÊÇΨһʵÑéÑо¿Ô¤·À¸ßѪѹÒýÆðÄÔѪ¹Ü²¡±äµÄ¶¯ÎïÄ£×Ó£¬ÊǺÍÈËÀàÄÔ×äÖÐ×î¿¿½üµÄ¶¯ÎïÄ£×Ó£¬Ó¦ÓÃ×î¹ã¡£

 

²Î¿¼ÎÄÏ×£º

1.ÖÓº½º££¬·ëÓ¢¿­£®ÂýÐÔ¸´ºÏÓ¦¼¤ÓÕ·¢¸ßѪѹ¶¯ÎïÄ£×ÓµÄÖƱ¸£®ÏÖ´úÒ½Ò©ÎÀÉú£¬2010, 26 (23):3523-3525

2.DiBona GF. Sympathetic nervous system and hypertension. Hypertension,2013, 61 (3):556-560

3.Domas WC.Silva ME. An.imal models for tl1e study of arterial hypertension. J Biosci,2011, 36 (4):731-737

4.Drenjancevic-Peric 1, Jelakovic B, Lombard J H, et al. High-salt diet and hypertension: focus on the reninangiolensin system. Kirlney Blood Press Res,201L,34(1): 1-11

5.Harrison M, Maresso K, Broeckel U. Genetic detenn.inants of hype.rlens.ion:an update. Curr Hyperlens Rep, 2008, 10 (6):488-495

6.Lerman LO,Chade AR,Sica V.el al. Animal models of hypertension:an ove.rview. J Lab Clin Med,2005, 146(3): 160-173

7.Li J, LaMarca B,Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine pe.rfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol,2012,303(1): Hl-8

8.Madero M,Perez-Pozo SE,Jalal D,et al. Dietary fructoseand hypertension. Curr Hyperteos Rep,2011,13(l):29-35

9.O'Toole TE, Conklin DJ, Bhatnagar A. Environmental risk factors for heart disease. Rev Environ Health, 2008, 23(3): 167-202

10.Queisser N,Schupp N. Aldosterooe,oxidative stress,and NF-kB activation i.n hypertension-related cardiovascular and renal diseases. Free Radie Biol Med,2012,53(2):314-327

11.Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res, 2008, 57 (6): 813-825

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÐÄѪ¹Üϵͳģ×Ó > ×Ô¾õÐÔ¸ßѪѹ¶¯ÎïÄ£×Ó
×Ô¾õÐÔ¸ßѪѹ¶¯ÎïÄ£×Ó

Ç°ÑÔ

¸ßѪѹÊÇÌåÑ­»·¶¯ÂöѹÔö¸ßµÄÒ»ÖÖ³£¼ûÐÄѪ¹Ü¼²²¡£¬ÓÉ»ùÒòºÍÇéÐζàÒòËØÏ໥×÷ÓÃÒýÆð£¬ÊÇÈ«Çò¹æÄ£ÄÚµÄÖØÖÁ¹«¹²ÎÀÉúÎÊÌ⣬¿É·ÖΪԭ·¢ÐÔ¸ßѪѹºÍ¼Ì·¢ÐÔ¸ßѪѹÁ½´óÀà¡£¸ßѪѹ¿ÉÒýÆðÉíÌå¶àÆ÷¹ÙË𺦣¬ÒÔÐÄ¡¢ÄÔ¡¢ÉöΪÖ÷¡£ÓÉÓÚ¸ßѪѹ·¢²¡ÒòËØÖØ´ó£¬ÓÖÊǶàÖÖ¼²²¡µÄΣÏÕÒòËØ£¬Òò´ËÐèÒª²î±ð¶¯ÎïÄ£×ÓÇø·Ö²î±ðÒÅ´«ºÍÇéÐÎÒòËØ£¬ÓÃÓÚÑо¿¸ßѪѹ²¡µÄ·¢²¡»úÖÆÒÔ¼°ºÍÆäËû¼²²¡µÄ¹Øϵ£¬ÕÒµ½Ô¤·ÀºÍÖÎÁƵÄÒªÁì¡£

¸ßѪѹ¶¯ÎïÄ£×Óƾ֤ÔìÄ£·½·¨¿ÉÒÔ·ÖΪÒÅ´«ÐÔÄ£×ӺͷÇÒÅ´«ÐÔÄ£×ÓÒÅ´«ÐÔÄ£×ÓÓеÄÊÇͨ¹ý½ü½»Ïµ×ÌÉúºÍ±íÐÍɸѡ£¬½¨Éè×ÔȻͻ±äµÄƷϵ£¬¶àÊÇ´óÊóÄ£×Ó¡£ÁíÒ»·½Ãæ¿ÉÒÔʹÓûùÒò¹¤³ÌÊÖÒÕ£¬Í¨¹ý»ùÒòÐÞÊλñµÃ¸ßѪѹģ×Ó¡£ÓÉÓÚСÊóµÄת»ùÒòºÍ»ùÒòÇóýÊÖÒյijÉÊ죬ÕâÀàÄ£×ÓÒÔСÊóÄ£×ÓΪÖ÷¡£·ÇÒÅ´«ÐÔÄ£×Ó¿ÉÒÔͨ¹ýÉöѪ¹ÜÊÖÊõ»ò¼¤ËØ¡¢Òûʳ¡¢Ò©Îï¡¢Ó¦¼¤µÈÓÕµ¼·½·¨ÖƱ¸¡£¶øÒÅ´«ÐÔÄ£×ӺͷÇÒÅ´«ÐÔÄ£×ÓµÄÏ໥͎ᣬ¸ü¿ÉÒÔÑо¿»ùÒòºÍÇéÐÎÒòËصÄÏ໥ӰÏì¡£½øÒ»²½ÍŽáÆäËûÏà¹Ø¼²²¡»ò æé¹ÙËðº¦Ä£×Ó£¬ÀýÈç¸ß֬Ѫ֢ģ×Ó¡¢ÒȵºËضԿ¹Ä£×Ó¡¢·ÊÅÖÄ£×ӵȣ¬Îª¸ßѪѹºÍÆäËû¼²²¡Ï໥¹ØϵµÄÑо¿ÒÔ¼°Ïà¹ØÖÎÁÆÒªÁìµÄ¡¢Ñо¿ÌṩºÜºÃµÄÑо¿¹¤¾ß¡£×ÜÖ®£¬ÏÖÔÚÑо¿¸ßѪѹ½ÓÄɶàÒòËصĶ¯ÎïÄ£×ӽ϶࣬¶¯ÎïÖÖÀàÒÔСÊó¡¢´óÊóÄ£×ÓΪÖ÷¡£Ëæ×Å´óÊóµÄ»ùÒòÇóýºÍת»ùÒòÊÖÒÕµÄÖð²½½¨ÉèÆðÀ´£¬ÆäÔÚ¸ßѪѹģ×ÓÖÐÓ¦ÓõÄÔöÌí½«Öð²½µØÌ滻СÊó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

×Ô¾õÐÔ¸ßѪѹ´óÊó(spontaneously hypertensive rat,SHR)ÊÇ1963ÄêOkamotoºÍAokiÅàÓý¶ø³ÉµÄ½ü½»ÏµWistar´óÊó¼°Æä±ÈÕÕϵ½ü½»ÏµWistar-Kyolo´óÊó¡£SHR´óÊó¸ßѪѹµÄ·¢²¡ºÍÐÄÊä³öÁ¿ÔöÌíÓйØ¡£Ëæ¸ßѪѹϣÍû£¬ÐÄÊä³öÁ¿»Ö¸´Õý³££¬¶ø×ÜÍâÖÜ×èÁ¦ÔöÌí¡£ºã¾Ã¿ÉÒýÆðÐļ¡·Ê´óºÍ³äѪÐÔÐĹ¦Ð§Ë¥½ß¡£

Ò××äÖÐÐÔ×Ô¾õÐÔ¸ßѪѹ´óÊó(stroke prone spontaneously hypertensive rat,SHRsp)ÊÇYamoriµÈ´Ó×ÔÈ»ËÀÓÚÄÔ×äÖеÄSHR´óÊó×ÓÅ®Öнü½»ÅàÓý¶ø³É¡£SHRºÍÆäÒõÐÔ±ÈÕÕÔÓ½»µÄµÚÒ»´úС×У¬±»³ÆΪÁÙ½çÐÔ¸ßѪѹ´óÊó(borderline hypertensive rat£¬BHR)£¬ÊÇÒ»Àà¶Ô¸ßѪѹÏà¹ØµÄÇéÐÎÒòËØÊ®·ÖÃô¸ÐµÄÄ£×Ó¡£ÑÎÃô¸ÐÐÔ´óÊó(Dahl salt-sensitive rat,DS)Ò²ÊÇÒ»Àà½ü½»ÏµÉ¸Ñ¡Ä£×Ó¡£±ðµÄһЩ·ÊÅÖÄ£×ÓÒ²±»ÒÔΪÊÇ×Ô¾õÐÔ¸ßѪѹģ×Ó¡£

¡¾Ä£×ÓÌص㡿£º

SHR(4~6ÖÜÁ䣩ÔÚÎÞÈκÎÎïÀíÒ©Îï¡¢ÊÖÊõµÈÒòËØÏ£¬×Ô¾õ¸ßѪѹ£¬¿ÉÊÇÇéÐÎÒòËØÓ°Ïì¸ßѪѹµÄˮƽ¡£¸ÃÄ£×Ó¶Ôζȡ¢Éù¡¢¹âµÈËÇÑøÇéÐÎÒªÇóÑÏ¿á¡£SHRËõ¶Ìѹͨ³£ÔÚ160mmHg (21.33kPa)ÒÔÉÏ£¬13ÖÜ×óÓÒ£¬Ðļ¡Ï¸°û·Ê´ó£¬24Öܺó×óÐÄÊұڷʺñ¾ÙÐÐÐÔ¼ÓÖØ£¬Ðļ¡½ºÔ­º¬Á¿ÏÔ×ÅÔöÌí£¬ÒÔºóÒòÈÕÒæ¼ÓÖصÄÐļ¡ÏËά»¯ºÍÐļ¡¼äÖÊÖع¹¶øÒýÆðÐÄÔàÊæËõ¹¦Ð§ÕÏ°­¡£SHRspÄ£×Ó6ÖÜѪѹ×îÏÈÉý¸ß£¬5¡«6ÔÂÁä´ïá¯Áë(230~250mmHg)¡£ÐÛÐÔƽ¾ùÊÙÃü9¸öÔ£¬´ÆÐÔ12¸öÔ£¬80£¥ÐÛÐÔ£¬60%´ÆÐÔ±¬·¢ÄÔ×äÖС£

¡¾Ä£×ÓȪԴ¡¿£º

SHRÏÖÔÚ³£ÓõÄÊÇÓÉOkamotoµÈÅàÓýµÄ¾©¶¼ÖÖ£¬ÆäËûÉÐÓжàÖÖȪԴµÄSHR´óÊó¡£ÎÒ¹úÉϺ£¸ßѪѹÑо¿Ëù¶¯ÎïʵÑéÖÐÐĵȵ¥Î»¿ÉÌṩSHR¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

SHR´óÊóÔÚ·¢²¡Ôµ¹ÊÔ­ÓÉÉÏÓëÈËÀà¸ßѪѹÓÐÒ»¶¨²î±ð£¬µ«´ÓÐí¶à·½ÃæÀ´½²£¬Èç·¢²¡»úÖÆ¡¢¸ßѪѹÐÄѪ¹Ü²¢·¢Ö¢¡¢ÍâÖÜѪ¹Ü×èÁ¦×ª±ä¡¢¶ÔÑεÄÃô¸ÐÐԵȶ¼ÓëÈËÀà¸ßѪѹ»¼ÕßÏàËÆ£¬ÊÇÏÖÔÚ¹ú¼Ê¹«ÈÏ×î¿¿½üÓÚÈËÀàÔ­·¢ÐÔ¸ßѪѹµÄ¶¯ÎïÄ£×Ó£¬¿ÉÓÃÓÚ¸ßѪѹ¼°²¢·¢Ö¢·¢²¡»úÖÆÑо¿£¬ÊǽµÑ¹Ò©Îïɸѡ»òҩЧÆÀ¼ÛµÄÀíÏëʵÑ鶯ÎïÄ£×Ó¡£

SHPspÄ£×ÓÊǹú¼Ê¸ßѪѹЭ»á¸ßѪѹ´óÊóÃüÃûίԱ»á(1986Äê8ÔµÚ11½ì¹ú¼Ê¸ßѪѹ¾Û»á£©ÍƼöµÄ¸ßѪѹʵÑéÄ£×Ó£¬ÊÇΨһʵÑéÑо¿Ô¤·À¸ßѪѹÒýÆðÄÔѪ¹Ü²¡±äµÄ¶¯ÎïÄ£×Ó£¬ÊǺÍÈËÀàÄÔ×äÖÐ×î¿¿½üµÄ¶¯ÎïÄ£×Ó£¬Ó¦ÓÃ×î¹ã¡£

 

²Î¿¼ÎÄÏ×£º

1.ÖÓº½º££¬·ëÓ¢¿­£®ÂýÐÔ¸´ºÏÓ¦¼¤ÓÕ·¢¸ßѪѹ¶¯ÎïÄ£×ÓµÄÖƱ¸£®ÏÖ´úÒ½Ò©ÎÀÉú£¬2010, 26 (23):3523-3525

2.DiBona GF. Sympathetic nervous system and hypertension. Hypertension,2013, 61 (3):556-560

3.Domas WC.Silva ME. An.imal models for tl1e study of arterial hypertension. J Biosci,2011, 36 (4):731-737

4.Drenjancevic-Peric 1, Jelakovic B, Lombard J H, et al. High-salt diet and hypertension: focus on the reninangiolensin system. Kirlney Blood Press Res,201L,34(1): 1-11

5.Harrison M, Maresso K, Broeckel U. Genetic detenn.inants of hype.rlens.ion:an update. Curr Hyperlens Rep, 2008, 10 (6):488-495

6.Lerman LO,Chade AR,Sica V.el al. Animal models of hypertension:an ove.rview. J Lab Clin Med,2005, 146(3): 160-173

7.Li J, LaMarca B,Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine pe.rfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol,2012,303(1): Hl-8

8.Madero M,Perez-Pozo SE,Jalal D,et al. Dietary fructoseand hypertension. Curr Hyperteos Rep,2011,13(l):29-35

9.O'Toole TE, Conklin DJ, Bhatnagar A. Environmental risk factors for heart disease. Rev Environ Health, 2008, 23(3): 167-202

10.Queisser N,Schupp N. Aldosterooe,oxidative stress,and NF-kB activation i.n hypertension-related cardiovascular and renal diseases. Free Radie Biol Med,2012,53(2):314-327

11.Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res, 2008, 57 (6): 813-825

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿